Jul 31, 2017 12:01 pm UTC| Business
The independent Data and Safety Monitoring Board (DSMB) reviewed safety and efficacy data, of which RedHill remains blinded, from the first 222 subjects who have completed week 26 assessments in the Phase III MAP US...
Ohr Pharmaceutical to Announce Fiscal Third Quarter 2017 Results on August 8
Jul 31, 2017 12:00 pm UTC| Business
NEW YORK, July 31, 2017 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for...
Altimmune to Announce Second Quarter 2017 Financial Results on August 10
Jul 31, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., July 31, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will report financial results for the three and six months ended June 30, 2017...
Uranium Resources Commences Lithium Exploration Drilling at the Columbus Basin Project
Jul 31, 2017 12:00 pm UTC| Business
CENTENNIAL, Colo., July 31, 2017 -- Uranium Resources, Inc. (Nasdaq:URRE) (ASX:URI), an energy metals development company, is pleased to announce the commencement of exploration drilling activities at its Columbus Basin...
Cannabix Technologies Develops Beta 3.0 Marijuana Breathalyzer and Provides Update
Jul 31, 2017 12:00 pm UTC| Business
VANCOUVER, British Columbia, July 31, 2017 -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is...
Jul 31, 2017 12:00 pm UTC| Business
HERNDON, Va., July 31, 2017 -- Command Security Corporation (NYSE MKT:MOC) today reported its financial results for its first fiscal quarter ended June 30, 2017. Revenues for the three months ended June 30, 2017...
Jul 31, 2017 12:00 pm UTC| Business
AUSTIN, Texas, July 31, 2017 -- Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND)...